Literature DB >> 5969089

Paroxysmal dysarthria and other transient neurological disturbances in disseminated sclerosis.

M L Espir, S M Watkins, H V Smith.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5969089      PMCID: PMC1064194          DOI: 10.1136/jnnp.29.4.323

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  15 in total

1.  THE TREATMENT OF TRIGEMINAL NEURALGIA: PRELIMINARY EXPERIENCE WITH 'TEGRETOL'.

Authors:  J D SPILLANE
Journal:  Practitioner       Date:  1964-01

2.  Paroxysmal dysarthria and ataxia in multiple sclerosis; a report of 2 unusual cases.

Authors:  F ANDERMANN; J B COSGROVE; D LLOYD-SMITH; A M WALTERS
Journal:  Neurology       Date:  1959-04       Impact factor: 9.910

3.  The clinician and the problem of multiple sclerosis.

Authors:  D McALPINE
Journal:  Lancet       Date:  1955-05-21       Impact factor: 79.321

4.  Cerebral dysrhythmia in disseminated sclerosis.

Authors:  B ASHWORTH; V EMERY
Journal:  Brain       Date:  1963-03       Impact factor: 13.501

5.  Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883).

Authors:  S BLOM
Journal:  Lancet       Date:  1962-04-21       Impact factor: 79.321

6.  Tonic seizures as a manifestation of multiple sclerosis.

Authors:  R J JOYNT; D GREEN
Journal:  Arch Neurol       Date:  1962-04

7.  Abnormal immunological reactions in disseminated sclerosis; a preliminary report.

Authors:  H V SMITH; M L ESPIR; C W WHITTY; W R RUSSELL
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

8.  Tonic seizures in disseminated sclerosis.

Authors:  W B MATTHEWS
Journal:  Brain       Date:  1958-06       Impact factor: 13.501

9.  Rare forms of paroxysmal trigeminal neuralgia, and their relation to disseminated sclerosis.

Authors:  W HARRIS
Journal:  Br Med J       Date:  1950-11-04

10.  The significance of localized vasoconstrictions in multiple sclerosis; transient, sudden miniature attacks of multiple sclerosis.

Authors:  R M BRICKNER
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1950
View more
  14 in total

1.  Paroxysmal symptoms in multiple sclerosis.

Authors:  W B Matthews
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-06       Impact factor: 10.154

2.  Paroxysmal brain stem dysfunction as presenting feature of multiple sclerosis.

Authors:  W H Perks; R G Lascelles
Journal:  Br Med J       Date:  1976-11-13

3.  Carbamazepine, a new symptomatic treatment for the paraesthesiae associated with Lhermitte's sign.

Authors:  K Ekbom
Journal:  Z Neurol       Date:  1971

4.  Transient neurological distrubances in disseminated sclerosis: a case report.

Authors:  M Harrison; J I McGill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-06       Impact factor: 10.154

5.  Migraine and multiple sclerosis.

Authors:  S M Watkins; M Espir
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-02       Impact factor: 10.154

6.  [Paroxysmal dysarthria and ataxia. A pathognomonic seizure syndrome in multiple sclerosis (author's transl)].

Authors:  P Wolf; H Assmus
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

7.  Paroxysmal symptoms as the first manifestations of multiple sclerosis.

Authors:  J A Twomey; M L Espir
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

8.  Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis.

Authors:  V Voiculescu; B Pruskauer-Apostol; C Alecu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-02       Impact factor: 10.154

9.  Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol).

Authors:  M L Espir; P Millac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

10.  Diagnosis and misdiagnosis of cerebrovascular disease.

Authors:  Vasileios-Arsenios Lioutas; Shruti Sonni; Louis R Caplan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.